Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bio-Rad financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.

Stock Price



Market Capitalization

$8.1 B



$2.7 B

FY, 2023

CreditSafe Score

Score changed on Jun 19, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2021FY, 2022FY, 2023
Revenue growth, %14.8%
Cost of goods sold1.3B1.2B1.2B
Gross profit1.6B1.6B1.4B
Gross profit margin, %56.1%55.9%53.4%
General and administrative expense879.6M827.8M841.7M
Operating expense total1.2B1.1B1.1B
EBIT margin, %16.7%17.2%12.6%
Interest expense1.6M38.1M49.4M
Pre tax profit5.4B(4.7B)(850.1M)
Income tax expense1.2B(1.1B)(212.8M)
Net Income4.2B(3.6B)(637.3M)

Acquisitions & Subsidiaries

Company nameDateDeal size
LoremDec 23, 2021$40.0M
IpsumJan 18, 2022$30.0M
Lorem IpsumFeb 18, 2022$25.0M
DolorOct 21, 2021$60.0M
Premium Content only available in Craft’s Intelligence Portal
View acquisitions and subsidiaries by company, date, and deal size.
Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm.
Learn more

Footer menu